Chlamydia Treatment
For uncomplicated genital Chlamydia trachomatis infection in non-pregnant adults, doxycycline 100 mg orally twice daily for 7 days is the preferred first-line treatment, with azithromycin 1 g orally as a single dose as an equally effective alternative when compliance is uncertain. 1
Non-Pregnant Adults: First-Line Treatment
The most recent CDC guidelines establish two co-equal recommended regimens 2, 1:
- Doxycycline 100 mg orally twice daily for 7 days
- Azithromycin 1 g orally as a single dose
Both regimens demonstrate equivalent efficacy (97-98% microbiological cure rates) in meta-analyses of randomized trials 1. However, emerging evidence from 2022 suggests doxycycline may be superior for rectal infections, with a 94% cure rate versus 85% for azithromycin (adjusted OR 0.43, p=0.0274) 3. A 2026 meta-analysis in men showed doxycycline achieved significantly higher cure rates overall (93% vs 81%, OR 2.525, p=0.005) 4.
Choosing Between Doxycycline and Azithromycin
Use doxycycline when:
- Patient compliance is reliable
- Cost is a consideration (doxycycline is less expensive)
- Rectal infection is present or suspected
- Symptomatic male urethritis
Use azithromycin when:
- Compliance with 7-day regimen is questionable
- Directly observed therapy is needed
- Patient populations with erratic healthcare-seeking behavior 2
Critical practice point: Dispense medications on-site and directly observe the first dose whenever possible 1.
Alternative Regimens for Non-Pregnant Adults
If first-line options cannot be used 1:
- Erythromycin base 500 mg orally four times daily for 7 days
- Erythromycin ethylsuccinate 800 mg orally four times daily for 7 days
- Ofloxacin 300 mg orally twice daily for 7 days
- Levofloxacin 500 mg orally once daily for 7 days
Note: Erythromycin has lower efficacy and frequent GI side effects that reduce compliance 1. Fluoroquinolones are more expensive and offer no dosing advantage over doxycycline.
Pregnant Women: Recommended Treatment
For pregnant women, azithromycin 1 g orally as a single dose is now the preferred first-line treatment, with amoxicillin 500 mg orally three times daily for 7 days as an equally recommended alternative 1.
Key Contraindications in Pregnancy
- Doxycycline is absolutely contraindicated (teratogenic)
- Ofloxacin and levofloxacin are contraindicated 1
- Erythromycin estolate is contraindicated (drug-related hepatotoxicity) 1
Recommended Regimens for Pregnancy 1:
- Azithromycin 1 g orally, single dose (preferred based on safety and efficacy data)
- Amoxicillin 500 mg orally three times daily for 7 days
Alternative Regimens for Pregnancy 1:
- Erythromycin base 500 mg orally four times daily for 7 days
- Erythromycin base 250 mg orally four times daily for 14 days
- Erythromycin ethylsuccinate 800 mg orally four times daily for 7 days
- Erythromycin ethylsuccinate 400 mg orally four times daily for 14 days
Critical difference for pregnant women: Test of cure is mandatory. Repeat testing (preferably by NAAT) 3 weeks after completion of therapy is required to ensure therapeutic cure and prevent maternal and neonatal complications 1. This is distinct from non-pregnant patients, where test of cure is not routinely recommended with azithromycin or doxycycline 1.
Lactating Women
The evidence does not provide specific separate recommendations for lactating women beyond pregnancy guidelines. Apply the same pregnancy-safe regimens (azithromycin or amoxicillin preferred, erythromycin alternatives, avoid doxycycline and fluoroquinolones).
Essential Management Components
Sexual Abstinence
Patients must abstain from sexual intercourse for 7 days after single-dose therapy OR until completion of 7-day regimen 1. Continue abstinence until all sex partners complete treatment to prevent reinfection.
Partner Management
- Treat all sex partners who had contact within 60 days preceding symptom onset or diagnosis 1
- Treat the most recent partner even if contact was >60 days ago
- Consider expedited partner therapy (providing prescription or medication directly to patient for partner) when standard referral is unlikely to succeed 1
Rescreening (Not Test of Cure)
Rescreen all women approximately 3 months after treatment to detect reinfection, which occurs frequently and increases PID risk 1. This is distinct from test of cure and addresses the high rate of reinfection from untreated partners.
Special Populations
HIV-Infected Patients
Use identical treatment regimens as HIV-negative patients 2, 1.
Adolescents
Standard adult regimens apply. Azithromycin safety in patients ≤15 years has not been fully established in older guidelines 5, though it is widely used. Fluoroquinolones should not be used in patients ≤17 years 5.
Common Pitfalls to Avoid
Do not routinely perform test of cure in non-pregnant patients treated with doxycycline or azithromycin unless compliance is questionable or symptoms persist 1
Do not test <3 weeks after treatment completion - false negatives from low organism numbers and false positives from dead organism excretion can occur 1
Do not forget to treat for concurrent gonorrhea when prevalence is high or testing unavailable 2
Do not use erythromycin estolate in pregnancy - hepatotoxicity risk 1
Do not assume partner treatment occurred - consider expedited partner therapy strategies 1